Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (7): 550-554.doi: 10.12372/jcp.2022.21e1174
• Literature Review • Previous Articles Next Articles
Reviewer: SONG Yating, Reviser: SUN Jianhua
Received:
2021-08-12
Online:
2022-07-15
Published:
2022-07-08
Reviewer: SONG Yating, Reviser: SUN Jianhua. Effects of systemic lupus erythematosus during pregnancy on offspring and its mechanism[J].Journal of Clinical Pediatrics, 2022, 40(7): 550-554.
[1] | Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies[J]. Clin Rev Allevgy Immunol, 2011; 40(1): 42-49. |
[2] |
Petri M. Pregnancy and systemic lupus erythematosus[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 64: 24-30.
doi: 10.1016/j.bpobgyn.2019.09.002 |
[3] | Eudy AM, Siega-Riz AM, Engel SM, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2018, 77(6): 855-860. |
[4] |
Mehta B, Luo Y, Xu J, et al. Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis[J]. Ann Intern Med, 2019, 171(3): 164-171.
doi: 10.7326/M19-0120 |
[5] |
Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study[J]. Ann Intern Med, 2015, 163(3): 153-163.
doi: 10.7326/M14-2235 pmid: 26098843 |
[6] |
Wang W, Irani RA, Zhang Y, et al. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia[J]. Hypertension, 2012, 60(3): 712-721.
doi: 10.1161/HYPERTENSIONAHA.112.191817 pmid: 22868393 |
[7] |
Viall CA, Chamley LW. Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature[J]. Autoimmun Rev, 2015, 14(5): 446-471.
doi: 10.1016/j.autrev.2015.01.008 pmid: 25620498 |
[8] |
Kim MY, Guerra MM, Kaplowitz E, et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies[J]. Ann Rheum Dis, 2018, 77(4): 549-555.
doi: 10.1136/annrheumdis-2017-212224 |
[9] |
Izmirly PM, Llanos C, Lee LA et al. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block[J]. Arthritis Rheum, 2010, 62(4): 1153-1157.
doi: 10.1002/art.27333 |
[10] |
Barsalou J, Costedoat-Chalumeau N, Berhanu A, et al. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus[J]. Ann Rheum Dis, 2018, 77(12): 1742-1749.
doi: 10.1136/annrheumdis-2018-213718 pmid: 30297329 |
[11] |
Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE)[J]. Expert Opin Drug Saf, 2017, 16(3): 411-419.
doi: 10.1080/14740338.2017.1269168 pmid: 27927040 |
[12] |
Barsalou J, Jaeggi E, Laskin CA, et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study[J]. Rheumatology(Oxford), 2017, 56(9): 1552-1559.
doi: 10.1093/rheumatology/kex191 |
[13] | Ayadi ID, Ben Hamida E, Boukhris MR, et al. Isolated anti-Ro/SSA thrombocytopenia: a rare feature of neonatal lupus[J]. Pan Afr Med J, 2015, 22(1): 312. |
[14] |
Wang YA, Sibbald C, Moon AT. Retrospective, single-center case series of neonatal lupus[J]. Pediatr Dermatol, 2020, 37(3): 484-489.
doi: 10.1111/pde.14132 |
[15] |
Kanda K, Sato A, Abe D, et al. The unique coexistence of anti-SS-A/Ro antibodies in a neonate with symptomatic ischemic stroke[J]. Pediatr Neurol, 2016, 62: 47-50.
doi: 10.1016/j.pediatrneurol.2016.06.005 |
[16] |
Dalal DS, Patel KA, Patel MA. Systemic lupus erythematosus and pregnancy: a brief review[J]. J Obstet Gynaecol India, 2019, 69(2): 104-109.
doi: 10.1007/s13224-019-01212-8 |
[17] |
Marder W. Update on pregnancy complications in systemic lupus erythematosus[J]. Curr Opin Rheumatol, 2019, 31(6): 650-658.
doi: 10.1097/BOR.0000000000000651 pmid: 31464707 |
[18] |
Vanoni F, Lava SAG, Fossali EF, et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review[J]. Clin Rev Allergy Immunol, 2017, 53(3): 469-476.
doi: 10.1007/s12016-017-8653-0 |
[19] |
Petri M. Pregnancy and systemic lupus erythematosus[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 64: 24-30.
doi: 10.1016/j.bpobgyn.2019.09.002 |
[20] |
Clancy RM, Halushka M, Rasmussen SE, et al. Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block[J]. J Immunol, 2019, 202(1): 48-55.
doi: 10.4049/jimmunol.1800357 |
[21] |
Strandberg LS, Cui X, Rath A, et al. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts[J]. PLoS One, 2013, 8(9): e72668.
doi: 10.1371/journal.pone.0072668 |
[22] |
Kan N, Silverman ED, Kingdom J, et al. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy[J]. Prenatal Diagn, 2017, 37(4): 375-382.
doi: 10.1002/pd.5021 |
[23] |
Meisgen S, Östberg T, Salomonsson S, et al. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence[J]. J Intern Med, 2014, 275(6): 640-651.
doi: 10.1111/joim.12179 pmid: 24354957 |
[24] | Ambrosi A, Salomonsson S, Eliasson H, et al. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern[J]. Ann Rheum Dis, 2012, 71(3): 334-340. |
[25] |
Sonesson SE, Ambrosi A, Wahren-Herlenius M. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies[J]. Ultrasound Obstet Gynecol, 2019, 54(1): 87-95.
doi: 10.1002/uog.20214 pmid: 30620419 |
[26] |
Fischer-Betz R, Haase I. Pregnancy with lupus erythe-matosus -an update[J]. Z Rheumatol, 2020, 79(4): 359-366.
doi: 10.1007/s00393-020-00772-9 pmid: 32236845 |
[27] |
Cuneo BF, Bitant S, Strasburger JF, et al. Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti‐Ro/SSA‐antibody‐positive pregnancies[J]. Ultrasound Obstet Gynecol, 2019, 54(5): 625-633.
doi: 10.1002/uog.20245 pmid: 30784137 |
[28] |
Østensen M. The use of biologics in pregnant patients with rheumatic disease[J]. Expert Rev Clin Pharmacol, 2017, 10(6): 661-669.
doi: 10.1080/17512433.2017.1305268 |
[29] | Kiriakidou M, Ching CL. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96. |
[30] |
Hoeltzenbein M, Elefant E, Vial T, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services[J]. Am J Med Genet A, 2012, 158A(3): 588-596.
doi: 10.1002/ajmg.a.35223 pmid: 22319001 |
[31] |
Bateman BT, Patorno E, Desai RJ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations[J]. Obstet Gynecol, 2017, 129(1): 174-184.
doi: 10.1097/AOG.0000000000001775 pmid: 27926639 |
[32] |
Yousef Yengej FA, van Royen-Kerkhof A, Derksen R, et al. The development of offspring from mothers with sys- temic lupus erythematosus. a systematic review[J]. Autoimmun Rev, 2017, 16(7): 701-711.
doi: 10.1016/j.autrev.2017.05.005 |
|